UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
UROCOR, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
91727P105
- --------------------------------------------------------------------------------
(CUSIP Number)
PETER A. LEIDEL, CONCORD PARTNERS II, L.P.
- --------------------------------------------------------------------------------
535 MADISON AVENUE, NEW YORK, NY 10022 (212) 906-7104
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
August 3, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4 Pages
<PAGE>
SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP No. 91727P105 Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(ENTITIES ONLY)
Concord Partners II, L.P.
- --------------------------------------------------------------------------------
I.R.S. No. 13-3421365
- --------------------------------------------------------------------------------
2 CHECK THE APPROXIMATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
N/A
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- --------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) |_|
N/A
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF None
SHARES ______________________________________________
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 824,028
REPORTING ______________________________________________
PERSON WITH 9 SOLE DISPOSITIVE POWER
None
----------------------------------------------
10 SHARED DISPOSITIVE POWER
824,028
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
824,028
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
N/A
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.9%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 2 of 4 Pages
<PAGE>
Item 1. Security and Issuer
This Amendment No. 1 amends the Statement on Schedule 13D with respect to
the common stock (the "Common Stock") of UroCor, Inc. (the "Company"),
previously filed on January 12, 1998 by the Reporting Person named therein (the
"Schedule 13D"). Capitalized terms used herein without definition shall have the
meanings given to such terms in the Schedule 13D.
Item 5. Interests in Securities of the Issuer
Item 5 is amended by adding the following:
(a) As of August 3, 1998, Concord II beneficially owns 824,028 shares
of Common Stock, representing 7.9% of the Outstanding Shares.
(c) Pursuant to its partnership agreement, on August 3, 1998, Concord
II distributed 300,000 shares of Common Stock to its partners, based on a
closing price of $6.75 per share. Of those shares, 62,400 were distributed to
its general partner, Venture Associates II, L.P., for further distribution to
its partners.
Page 3 of 4 Pages
<PAGE>
SIGNATURES
The undersigned certify that, after reasonable inquiry and to the best of
their respective knowledge and belief, the information set forth in the Schedule
13D/A is true, complete and correct.
CONCORD PARTNERS II, LP
By: Venture Associates II, L.P.
its General Partner
By: CPML Associates, Inc.
its General Partner
By: /s/ Peter A. Leidel
-------------------------------------
Name: Peter A. Leidel
Title: Attorney-in-Fact
Dated: August 7, 1998
Page 4 of 4 Pages
